ABOUT US

Built for Enforcement. Designed for Scale.

Today, animal movement often relies on paper documents, screenshots, and manual interpretation. These methods introduce biosecurity risk, operational inconsistency, and regulatory exposure. Immuniscan exists to replace fragmented verification processes with standardized authorization infrastructure that can be trusted globally.

Immuniscan is built to support:

Veterinarians and animal health professionals
Transport operators and logistics providers
Shelters, rescues, and welfare organizations
Pharmaceutical and research organizations
Hospitality and public access venues
Governments, regulators, and enforcement agencies

Immuniscan was created to serve as foundational infrastructure for animal movement authorization worldwide.

The platform is designed for environments where accuracy, durability, auditability, and regulatory integrity matter — including borders, transport hubs, facilities, and public venues.

This is not consumer software.

This is authorization infrastructure for animal movement.

Immuniscan is not a consumer application and not a veterinary diagnostic tool. It is infrastructure.

Our mission is to ensure that animals move safely, lawfully, and verifiably — protecting:

Public health

Regulatory compliance

Animal welfare

Operational continuity

Why Immuniscan Exists

Animal movement and access decisions increasingly occur in high-consequence environments—airports, borders, shelters, venues, research facilities, and quarantine centers—where inconsistency or error can result in serious operational, public health, and regulatory consequences.

Immuniscan was built to support these environments by providing a clear authorization layer that links animal identity to readiness indicators and policy logic. The platform enables consistent decision-making while respecting the authority of veterinarians, regulators, and operators.

Discover how Immuniscan supports safer, more consistent animal authorization worldwide.

The Team

Leadership

Immuniscan is led by a multidisciplinary team with experience spanning enterprise technology, regulatory automation, clinical operations, veterinary compliance, border security, and global animal travel. This diversity of expertise allows the platform to operate credibly at the intersection of technology, regulation, and real-world enforcement.

Matthew C. James

Founder/CEO

Matthew C. James brings more than 25 years of experience in business, enterprise technology, and regulatory automation. He previously served as a Senior Technology Lead at Accenture, where he worked on large-scale systems supporting highly regulated industries. His background includes enterprise architecture, compliance-driven automation, and infrastructure design. At Immuniscan, Matthew is responsible for platform vision, system architecture, and ensuring the solution aligns with the operational realities of governments, enterprises, and global stakeholders.

LinkedIn: Matthew C. James | LinkedIn

Kelli Taylor

Clinical Operations Advisor

Kelli Taylor brings deep expertise in clinical operations, organizational process design, and stakeholder coordination. Her experience includes scaling workflows in environments where accuracy, compliance, and accountability are critical. At Immuniscan, she focuses on aligning platform workflows with real-world operational needs and ensuring deployments integrate seamlessly into existing organizational processes.

LinkedIn: Kelli Taylor | LinkedIn

Erin Terjesen

Industry Marketing Advisor

Erin Terjesen is a respected strategist in the animal and pet industry with deep insight into market dynamics, stakeholder needs, and adoption challenges across the ecosystem. Her role at Immuniscan centers on strategic positioning, industry engagement, and ensuring the platform addresses the practical realities faced by animal health professionals, organizations, and partners worldwide.

LinkedIn: Erin Terjesen | LinkedIn

Dr. Ali Raza

International Veterinary Advisor

Dr. Ali Raza is a veterinarian with experience in international compliance, veterinary workflows, and global animal health requirements. At Immuniscan, Dr. Raza advises on regulatory integrity and veterinary alignment, helping ensure the platform supports existing veterinary and regulatory frameworks across jurisdictions.

LinkedIn: Ali Raza | LinkedIn

Advisors

Immuniscan is supported by advisors with specialized expertise in global animal travel, border operations, and biosecurity oversight. Advisory input informs platform decisions and reinforces the company’s focus on enforcement-grade authorization, auditability, and regulatory alignment.

Dr. Nelva Bryant

Chief Advisor – Air & Global Pet Travel

Dr. Nelva Bryant is widely recognized as one of the leading authorities on air and global pet travel. Her expertise spans airline policies, international movement requirements, and real-world travel challenges. As Chief Advisor, Dr. Bryant provides strategic guidance to ensure Immuniscan reflects the realities of pet travel across airlines and borders while maintaining compliance and safety.

LinkedIn: LinkedIn

Senior Homeland Security Advisor

Border Security & Biosecurity Oversight

Immuniscan is advised by a senior Homeland Security expert with extensive experience in border processes, identity systems, and security oversight. This advisory role supports Immuniscan’s focus on enforcement-grade authorization, auditability, and alignment with border control and inspection operations.

working together

Governance & Credibility

Immuniscan operates with a governance mindset appropriate for enterprise and government deployment. Advisory input from veterinary, regulatory, and security professionals ensures the platform aligns with existing authorities rather than attempting to replace them.

The company prioritizes regulatory respect, operational realism, accountability, and long-term infrastructure integrity.

Request a demo or request a government briefing to learn more.

Learn More

Discover how Immuniscan supports safer, more consistent animal authorization worldwide.